Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.660
-0.040 (-2.35%)
At close: Apr 29, 2026, 4:00 PM EDT
1.730
+0.070 (4.22%)
After-hours: Apr 29, 2026, 5:39 PM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $104.3 million as of April 29, 2026. Its market cap has increased by 76.64% in one year.
Market Cap
104.30M
Enterprise Value
55.80M
1-Year Change
76.64%
Ranking
Category
Stock Price
$1.66
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $104.30M, a decrease of -80.09%. That is a compound annual growth rate of -29.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 106.81M | 49.17% |
| Dec 31, 2025 | 71.60M | -22.81% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cognition Therapeutics | 111.69M |
| Verrica Pharmaceuticals | 111.66M |
| Aardvark Therapeutics | 111.26M |
| Cardiff Oncology | 111.09M |
| Genelux | 110.49M |
| Cibus | 106.41M |
| PepGen | 106.30M |
| Biomea Fusion | 106.28M |